Insider · CIK 0001860597
Brian M. Silver
Files at TCRX (TScan Therapeutics, Inc.). First filing Dec 29, 2022, latest Dec 29, 2022.
In brief
Brian M. Silver files SEC Form 4 as CFO at TCRX (TScan Therapeutics, Inc.). Since Dec 29, 2022, Brian M. Silver has reported 1 open-market buy worth $9,217 and 0 open-market sells worth $0, the latest filed on Dec 29, 2022.
A track record needs three past buys with six months of prices behind them; Brian M. Silver has 0, so none is measured yet.
The newest scored trade: bought $9,217 of TCRX on Dec 27, 2022, filed Dec 29, 2022, scored 46 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TCRX: TScan Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | TCRXbuy TScan Therapeutics, Inc. | $9,217 6,000 shares | +22% | 0% from low-72% from high |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 27, 2022 | TCRX TScan Therapeutics, Inc. | POpen-market purchase Voting Common Stock | +2,842 | $1.50 | $4,276 | 29,727 | Dec 29, 2022 |
| Dec 28, 2022 | TCRX TScan Therapeutics, Inc. | POpen-market purchase Voting Common Stock | +3,158 | $1.56 | $4,941 | 32,885 | Dec 29, 2022 |
Questions about Brian M. Silver
Answered from the filings on this page, as of the latest one.
Is Brian M. Silver buying or selling?
Not in the last 12 months. Brian M. Silver's latest open-market trade on SEC Form 4 was bought $9,217 of TCRX on Dec 27, 2022.
How did Brian M. Silver's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brian M. Silver has 0.
Where does Brian M. Silver file Form 4?
Brian M. Silver has filed Form 4 at TCRX (TScan Therapeutics, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.